Weiss Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Weiss Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,552	Closed	-$254K	–	500
2018 Q3	$254K	Hold	9,552	–	–	0.02%	138
2018 Q2	$218K	Hold	9,552	–	–	0.02%	136
2018 Q1	$203K	Buy	+9,552	New	+$145K	0.02%	159

Other funds holding MYOV

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Weiss Asset Management's MYOV Position: Q4 2018 in Review

Weiss Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2018, closing a stake of 9,552 shares — an estimated $254K sold.

Weiss Asset Management first reported a position in MYOV in Q1 2018 and held it in 3 quarters. The position peaked at $254K in Q3 2018. 30 funds tracked by Wall St. Rank hold MYOV as of Q4 2018.

Weiss Asset Management reported no remaining Myovant Sciences Ltd. position as of Q4 2018 after selling out during the quarter.
Weiss Asset Management sold 9,552 Myovant Sciences Ltd. shares in Q4 2018, an estimated $254K.
Weiss Asset Management first reported a position in Myovant Sciences Ltd. in Q1 2018 and held it in 3 quarters.
Weiss Asset Management's Myovant Sciences Ltd. position peaked at $254K in Q3 2018.
30 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2018.

Based on Weiss Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.